NoNO Inc. Announces First Patient Dosed with NoNO-42 in a First in Humans Phase 1 Study. LEARN MORE
Skip to content
Board of Directors
Scientific Advisory Board
News and Media
This author has not yet filled in any details.
So far NoNO Inc has created 0 blog entries.